BCTX

BriaCell Therapeutics Corp.

3.41 USD
-0.02 (-0.58%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

BriaCell Therapeutics Corp. stock is down -20.33% since 30 days ago. The next earnings date is Mar 12, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 13 February’s closed higher than January. In the last 3 Unusual Options Trades, there were 2 CALLs, 1 PUT.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
04 Jan 18:22 19 Apr, 2024 7.50 CALL 1754 1442
18 Jan 15:05 19 Jul, 2024 7.50 PUT 58 0
20 Feb 15:29 19 Jul, 2024 7.50 CALL 1000 1447

About BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp. engages in developing immunotherapies for the treatment of cancer. Lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors. Company also has a cooperative research and development agreement with the National Cancer Institute.